Vascular disrupting agents

J Thorac Oncol. 2010 Dec;5(12 Suppl 6):S482-3. doi: 10.1097/01.JTO.0000391376.09556.d8.
No abstract available

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Clinical Trials as Topic
  • Humans
  • Lung Neoplasms / blood supply*
  • Neovascularization, Pathologic / prevention & control*

Substances

  • Angiogenesis Inhibitors